PARKINSON DISEASE (Disorder) Clinical Trials
15 studies are recruiting for parkinson disease (disorder) in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Treatment of Cognitive and Sensorimotor Deficits in Parkinson's Disease With High Definition Transcranial Direct Current Stimulation
The purpose of this research study is to examine the effects of transcranial Direct Current Stimulation (tDCS) on verbal retrieval and cognition and sensorimotor control and to determine if tDCS can be used as a way to improve retrieval, sensory, and motor abilities in individuals with Parkinson's …
- Stage
- Not phased
- Ages
- 50 to 90
- Site
- Callier Clinical Center, The University of Texas at Dallas, Richardson, Texas
- Run by
- The University of Texas at Dallas
-
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
Vista PD is a randomized, placebo-controlled, multicenter study to evaluate the efficacy, PK, safety, and tolerability of VIM0423 in adults with Parkinson's disease tremor insufficiently responsive to dopaminergic therapy. The main objectives of this clinical trial are to determine the following: *…
- Stage
- Phase 2
- Ages
- 18 to 65
- Site
- Vima Site #002, Farmington Hills, Michigan
- Locations
- 30 in total
- Run by
- Vima Therapeutics
-
Optimizing Adaptive DBS for Parkinson's Disease
Parkinson's disease (PD) affects more than 10 million people worldwide and causes progressive motor symptoms such as slowness, stiffness and tremor. For patients whose symptoms are no longer adequately controlled with medication, deep brain stimulation (DBS) can substantially improve motor function…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- UC Davis Center for Neuroscience, Davis, California
- Run by
- University of California, Davis
-
GBPDC: Gut-Brain in PD Consortium Master Protocol
The purpose of this research study is to identify the role that the gut-brain axis, the group of nerves that connect the brain and gut, plays in Parkinson's disease (PD). The National Institute of Diabetes and Digestive and Kidney Diseases is sponsoring this research study. During this study, speci…
- Stage
- Not phased
- Ages
- 21 to 80
- Site
- Stanford University, Stanford, California
- Locations
- 7 in total
- Run by
- Duke University
-
Multicontext Approach for Cognitive Function in Parkinson Disease
Mild cognitive decline is common in early Parkinson disease (PD) and is associated with disability, reduced quality of life (QOL), and increased risk for dementia. Medical treatments for PD do not prevent or treat cognitive decline and may even exacerbate the problem. Unfortunately, existing cognit…
- Stage
- Not phased
- Ages
- 50 and older
- Site
- Washington University School of Medicine, St Louis, Missouri
- Run by
- Washington University School of Medicine
-
Using taVNS to Modulate Cardiovascular Function in Individuals With Neurologic Disease
The purpose of this study is to find out whether a type of gentle nerve stimulation, called transcutaneous auricular Vagus Nerve Stimulation (taVNS), can help improve how the body regulates heart rate and blood pressure in people with Parkinson's Disease (PD). Problems with heart rate and blood pre…
- Stage
- Phase 1
- Ages
- 18 to 80
- Site
- Wellness, Health and Research Facility at UAB, Birmingham, Alabama
- Run by
- University of Alabama at Birmingham
-
Effects of Accelerated rTMS On Motor and Cognitive Function in Parkinson's Disease
Parkinson's disease (PD) is a brain disorder that causes progressive problems with movement, such as slowness, stiffness, tremor, and difficulty walking. Many people with PD also develop problems with thinking and memory. Current medications can help control movement symptoms but often become less …
- Stage
- Not phased
- Ages
- 50 to 90
- Site
- San Francisco Neurology and Sleep Center, San Francisco, California
- Run by
- San Francisco Neurology and Sleep Center
-
SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
This is a randomized, placebo-controlled, single ascending dose (SAD) study of SER-252 in participants with Parkinson's Disease (PD) and motor fluctuations.
- Stage
- Phase 1
- Ages
- 40 to 80
- Site
- Velocity Clinical Research, Hallandale, Florida
- Locations
- 6 in total
- Run by
- Serina Therapeutics
-
Adapting rHIRE and Sleep Monitoring in Parkinson's Disease
Exercise is a primary intervention for symptom management in Parkinson's Disease (PD). However, challenges related to transportation, mobility, and socioeconomic factors often hinder consistent participation in exercise programs. To promote increased access and participation, remote exercise progra…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Colorado Anschutz Medical Campus, Aurora, Colorado
- Run by
- University of Colorado, Denver
-
Effects of an Independent Walking Program With Walking Poles in People With Parkinson Disease
Study Purpose: The purpose of the study is to compare changes in walking in people with Parkinson disease after an 8-week independent walking program with or without using walking poles. Major parts of the Study: Before the walking program: Measurements will be taken of you while you are walking. Y…
- Stage
- Not phased
- Ages
- Any age
- Site
- East Tennessee State University, Johnson City, Tennessee
- Run by
- East Tennessee State University
-
Steady Together Fall Prevention Program in the Home
The purpose of the research study is to assess the efficacy of the occupational therapy Steady Together Fall Prevention Program in the Home for persons with Parkinson's Disease (PwP) who are members of InMotion. InMotion is a community wellness center that offers a variety of programs for PwP. The …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- InMotion Wellness Center, Beachwood, Ohio
- Run by
- Cleveland State University
-
Effects of Vagal Nerve Stimulation on Leg Muscle Activity and Posture in Parkinson's Disease
This study is designed to better understand the mechanisms contributing to impaired activation of leg muscles in people with Parkinson's disease (PD) and to test if stimulation of a nerve at the neck can improve muscle activation, walking and balance.
- Stage
- Not phased
- Ages
- 21 to 76
- Site
- Movement Disorders Laboratory, Minneapolis, Minnesota
- Run by
- University of Minnesota
-
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
The goal of this observational study is to learn whether tissue samples taken from the colon during routine colonoscopy can detect signs of Parkinson's disease. The main question it aims to answer is: Can doctors find a protein called alpha-synuclein in colon tissue samples from people with Parkins…
- Stage
- Not phased
- Ages
- 40 to 99
- Site
- Oregon Health & Science University, Portland, Oregon
- Run by
- CND Life Sciences
-
Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder
The goal of this observational study is to learn whether tissue samples taken from the colon during routine colonoscopy can detect signs of Parkinson's disease or REM Sleep Behavior Disorder (RBD). The main question it aims to answer is: Can doctors find a protein called alpha-synuclein in colon ti…
- Stage
- Not phased
- Ages
- 40 to 99
- Site
- Digestive Disease Associates, Branford, Connecticut
- Run by
- CND Life Sciences
-
Virtual tES Device Treatment for Parkinson's Disease Motor Symptoms
This study tests a new, non-invasive brain stimulation device called Sphere V3.0 to help improve movement problems in people with Parkinson's disease. The device delivers gentle electrical signals to the scalp using small electrodes placed on the head. Participants will use the device at home for 1…
- Stage
- Phase 1
- Ages
- 18 to 80
- Site
- U LLC Headquarters, Cleveland, Ohio
- Run by
- U: The Mind Company
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.